Top

Published in:

Open Access 01-09-2022 | Schizophrenia | Correction

Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Authors: C. U. Correll, Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Niko Seppälä, Oliver D. Howes

Published in: CNS Drugs | Issue 9/2022

Excerpt

This article was published online on June 27, 2022. An error was subsequently identified in the article, and the following correction should be noted: …

Title: Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Authors: C. U. Correll
Ofer Agid
Benedicto Crespo-Facorro
Andrea de Bartolomeis
Andrea Fagiolini
Niko Seppälä
Oliver D. Howes
Publication date: 01-09-2022
Publisher: Springer International Publishing
Keywords: Schizophrenia
Clozapine
Published in: CNS Drugs / Issue 9/2022
Print ISSN: 1172-7047
Electronic ISSN: 1179-1934
DOI: https://doi.org/10.1007/s40263-022-00946-w

2024 ASCO Annual Meeting

Springer Medicine

Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia

Excerpt

2024 ASCO Annual Meeting

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2022

Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy

Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability

Treatment Options in Refractory Autoimmune Encephalitis

Sodium Phenylbutyrate and Ursodoxicoltaurine: First Approval

Correction to: Antiseizure Drugs and Movement Disorders

Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study